<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03685214</url>
  </required_header>
  <id_info>
    <org_study_id>2018010</org_study_id>
    <nct_id>NCT03685214</nct_id>
  </id_info>
  <brief_title>Comparison of Balanced Crystalloids and Normal Saline in Septic Patients</brief_title>
  <official_title>Comparison of Balanced Crystalloids and Normal Saline in Septic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ZhiYong Peng</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wu Jieping Medical Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Zhongnan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective randomized controlled trial, investigators attempt to study the effects
      of acetated Ringer's solution on the prognosis and renal function of patients with sepsis in
      intensive care unit compared with normal saline, and provide evidence for current fluid
      resuscitation strategies for sepsis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During the study period，either normal saline or acetated Ringer's solution will be assigned
      as resuscitation fluid to the septic patients meeting the inclusion criteria.It is
      anticipated that about 500 patients will be enrolled during the study period.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>One model using normal saline for resuscitation fluid,the other using acetated Ringer's solution</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Development of kidney injury as defined by the KDIGO criteria.</measure>
    <time_frame>5 days after the admission</time_frame>
    <description>Investigators will use the level of creatinine(μmol/L) and body weight adjusted urine(ml/h/kg) for severity assessment of kidney injury</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Need of renal replacement treatment</measure>
    <time_frame>After the admission and before the discharge from ICU,average 15 days</time_frame>
    <description>Investigators will assess patients' kidney function everyday</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU stay</measure>
    <time_frame>After the admission and before the discharge from ICU,average 15 days</time_frame>
    <description>the time of patients' requirement for critical care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28 days mortality</measure>
    <time_frame>28 days after the admission in ICU</time_frame>
    <description>the short time mortality</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Sepsis</condition>
  <condition>Acute Kidney Injury</condition>
  <condition>Septic Shock</condition>
  <condition>Sepsis, Severe</condition>
  <arm_group>
    <arm_group_label>0.9% saline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>We use 0.9% saline for resuscitation fluid in ICU septic patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Balanced Crystalloids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>We use acetated Ringer's solution for resuscitation fluid in ICU septic patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% saline</intervention_name>
    <description>we use 0.9% saline in ICU patients with sepsis for resuscitation fluid.</description>
    <arm_group_label>0.9% saline</arm_group_label>
    <other_name>normal saline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lactated Ringer's solution</intervention_name>
    <description>we use balanced balanced crystalloids in ICU patients with sepsis for resuscitation fluid.</description>
    <arm_group_label>Balanced Crystalloids</arm_group_label>
    <other_name>Ringer's lactate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed sepsis aged 18~75 and accepted therapy in ICU

        Exclusion Criteria:

          -  Need of Renal replacement treatment

          -  End-stage renal failure

          -  pregnant woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ZhiYong Peng, professor</last_name>
    <role>Study Director</role>
    <affiliation>Zhongnan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Li He, investigator</last_name>
    <phone>008617798258617</phone>
    <email>helisoul@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Li He</last_name>
    <phone>008617798258617</phone>
    <email>helisoul@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongnan Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>434000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ying Feng</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>August 15, 2018</study_first_submitted>
  <study_first_submitted_qc>September 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2018</study_first_posted>
  <last_update_submitted>March 23, 2019</last_update_submitted>
  <last_update_submitted_qc>March 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Zhongnan Hospital</investigator_affiliation>
    <investigator_full_name>ZhiYong Peng</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>sepsis</keyword>
  <keyword>intensive care unit</keyword>
  <keyword>acetated Ringer's solution</keyword>
  <keyword>AKI</keyword>
  <keyword>normal saline</keyword>
  <keyword>prognosis</keyword>
  <keyword>continuous renal replacement therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

